Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
SANB was delisted on the 19th of October, 2022.
0 hedge funds and large institutions have $0 invested in Sanaby Health Acquisition Corp. I Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 61 closing their positions.
100% less funds holding
Funds holding: 61 → 0 (-61)
100% less capital invested
Capital invested by funds: $170M → $0 (-$170M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 61
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$12M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$11.5M |
| 3 |
SC
Sculptor Capital
New York
|
-$10.8M |
| 4 |
MMA
Mizuho Markets Americas
New York
|
-$8.51M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$7.53M |
SANB Hedge Fund Activity: Q4 2022 in Review
0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) for Q4 2022, worth a combined $0 — down 100% from $170M a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of SANB and 0 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Saba Capital Management, exiting entirely with an estimated $12M sold.
- 0 institutional investors held Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) as of Q4 2022, down from 61 in Q3 2022.
- Funds reported $0 of Sanaby Health Acquisition Corp. I Class A Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Sanaby Health Acquisition Corp. I Class A Common Stock positions in Q4 2022 and 61 closed out, a net change of -61 holders.
- The largest Sanaby Health Acquisition Corp. I Class A Common Stock seller in Q4 2022 was Saba Capital Management, an estimated $12M sold.
Based on aggregated 13F filings for Q4 2022.